ARNA +4.09% @ 10.43, 6.1M ARNA sold off after the big news on June 27th of gaining FDA approval for its diet drug which will be marketed under the name Belviq. It seems to be finding its legs in recent sessions. I suspect some investors in competitor VVUS are switching horses. MG
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.